pralatrexate

Trials studying pralatrexate

• phase3Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphomarecruitingn=150
• phase1Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCLactive not recruitingn=37
• phase1Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairmentrecruitingn=24
• phase2Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCLrecruitingn=50
• phase3To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLrecruitingn=504
• phase2KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)completedn=71
• phase2Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphomacompletedn=34